News to Use

  • IU completes salvage auctions at former Wishard complex

    IU is selling material from a number of buildings that comprised the former William N. Wishard Memorial Hospital complex as part of auctioning process concluding today, Feb. 26.

    The auctions, which aim to salvage assets such as mechanical components to cabinetry, provide bidders until late March to remove their purchased items, after which IU will begin demolition of some buildings and the repurposing of others, according to Richard Thompson of the University Architect’s Office.

    “We wanted our process to fulfill the needs of IU, but also to respect the long and illustrious history of Wishard Hospital and all it has meant to the city of Indianapolis, and to the people whose lives have been enriched by the care they received in that facility,” Thompson said.

    Preparations for the auction started in mid-2010 and required an assessment of each Wishard building to see what could continue to be used and what could be salvaged. Thompson said environmental concerns are typical for older facilities, particularly hospitals, but remaining infrastructure attached to the buildings still has value. Items as steel, brick and concrete have particularly strong potential for reuse or recycling.

    The salvage process will leave eight buildings from the Wishard complex available for renovation and reuse, and 10.88 acres for future development.

    Back to Top ▲

  • Zubin Damania (aka ZDoggMD) to present 'Healthcare, Remixed' on March 4

    Zubin Damania, M.D.,  whose humor about America's health care system has made him an Internet celebrity also known as ZDoggMD, will present "Healthcare, Remixed" from 1 to 2:30 p.m. Wednesday, March 4, at Hine Hall at IUPUI. Check-in for the event begins at 12:30 p.m.

    An internist who received training at the Stanford University School of Medicine, Dr. Damania is the founder of Turntable Health, an innovative healthcare startup that’s part of an ambitious urban revitalization movement spearheaded by CEO Tony Hsieh.

    This event is free and open to the public but tickets are required. For more information, or for tickets, visit

    This event is presented by the IU School of Nursing, Indiana University Center for Interprofessional Health Education and Practice, Indiana Area Health Education Centers and the Department of Emergency Medicine at the IU School of Medicine.

    Questions to Sally Krause at

    Back to Top ▲

  • 'Conversations About Cancer' series premieres March 10

    WFYI and "Sound Medicine" will present a three-part series of "Conversations About Cancer" starting March 10 in advance of Ken Burn's new documentary, "The Story of Cancer: The Emperor of All Maladies," which premieres on WFYI March 30.

    All presentations will be held at 6:30 p.m. Speakers and topics are:

    • March 10: "Living With Hope, Coping With Uncertainty" at the Christel DeHaan Fine Arts Center, University of Indianapolis. Speakers are Larry Cripe, M.D., of the IU Simon Cancer Center and IU School of Medicine; Karen Iseminger, Ph.D., of the University of Indianapolis and a cancer survivor; and Dale Theobald, Ph.D., M.D., of the Community Home Health Hospice and Symptom Management Group.
    • March 18: "New Directions in Treatment" at the IUPUI Campus Center Theatre, Room 002. Panelists are Patrick Loehrer, Sr., M.D., director of the IU Simon Cancer Center and of the IU School of Medicine; Larry Einhorn, M.D., of the IU Simon Cancer Center and IU School of Medicine; and David Flockhart, M.D., director of the Indiana Institute for Personalized Medicine at the IU School of Medicine. (Free parking available in the Vermont Street Garage.)
    • March 26: "Spirituality and Cancer" at the Restoration Baptist Church, 1502 N. New Jersey St., Indianapolis. Panelists are Steven S. Ivy, Ph.D., of IU Health; Lisa Hayes, JD, of the Gennesaret Free Clinic and a cancer survivor; and Eric Hayes, Sr., of the Restoration Baptist Church.

    In addition, "Sound Medicine" will air a special episode on March 22 featuring an interview with Dr. Einhorn, IU Distinguished Professor and Livestrong Foundation Professor of Oncology at the IU School of Medicine, and patient John Cleland, who was cured of testicular cancer with Dr. Einhorn's landmark treatment 40 years ago. The episode will also feature a visit to the Komen Tissue Bank at the IU Simon Cancer Center and an interview with Siddhartha Mukerjee, M.D., author of "The Emperor of All Maladies: A Biography of Cancer."

    The "Conversations About Cancer" series is sponsored by WFYI Public Media and Sound Medicine Radio Hour, in partnership with IU Simon Cancer Center, University of Indianapolis and Restoration Baptist Church.

    All events are free and open to the public. For more information, visit the WFYI events page.

    Back to Top ▲

Research News

  • IU researchers identify patients who may benefit from specific pancreatic cancer treatment

    Cancer researchers at IU report that about 15 percent of people with pancreatic cancer may benefit from therapy targeting a newly identified gene signature.

    Using data from the Cancer Genome Atlas, Murray Korc, M.D., the Myles Brand Professor of Cancer Research at the IU School of Medicine and a researcher at the IU Simon Cancer Center, and colleagues found that a sub-group of pancreatic cancer patients who possess a strong angiogenic gene signature could benefit from personalized therapies that cut off the pathways that feed the cancer’s growth.

    This particular gene signature enables abnormal blood vessels to form in tumors, which feeds the tumor's growth.

    The finding, published online Feb. 25 in the journal Oncotarget, is new because the prevalence of this signature was not previously known. The authors also demonstrated for the first time that endothelial cells, the main type of cell found in the inside lining of blood vessels, can produce molecules that directly stimulate the growth of pancreatic cancer cells. 

    For more information, visit the IUSM Newsroom.

    Back to Top ▲

Faculty and Staff News

  • Carlson to direct Indiana University Clinical Trials Office

    Kenneth H. Carlson has been named director of the Clinical Trials Office for University Clinical Affairs at Indiana University. He began his new position on Feb. 25.

    The Clinical Trials Office, established in July 2014, serves as the single point of entry for clinical trials across IU, providing streamlined support for the facilitation of research studies, including contracting, budgeting and metric tracking.

    "I am delighted that Ken has agreed to join IU," said Anantha Shekhar, M.D., Ph.D., director of the Indiana Clinical and Translational Sciences Institute, associate dean for translational research at the IU School of Medicine and associate vice president for university clinical affairs at IU. "As the director of the IU Clinical Trials Office, he will bring deep understanding about what industry partners are looking for when placing clinical trials at academic medical centers, and how the clinical trials business is evolving across the globe. This will help propel IU to become a preferred clinical research partner for a wide range of biomedical industries." 

    In this position, Carlson provides strategic leadership to the Clinical Trials Office, including advancing the timely and efficient conduct of industry sponsored clinical trials at IU and its health care partners of IU Health and Eskenazi Health. He is responsible for the overall management of the office, its staff and resources, and will set policies and procedures for ensuring quality service and increased participation in clinical trials. He also will engage current and new clinical trial sponsors, and maintain existing sponsor relationships, to increase the overall number of clinical trials conducted at IU.

    Prior to joining the university, Carlson served 19 years at Eli Lilly and Co. in multiple positions dedicated to early and late phase drug development, most recently as the manager of global sourcing and study delivery solutions in the division of clinical pharmacology. He has also been the associate director of project planning and management at Eli Lilly's affiliate in Kobe, Japan, and the manager of the integration of clinical pharmacology strategy, planning and operations for Lilly Japan and global clinical pharmacology operations in U.S., Europe and Singapore. He also previously served as a toxicologist with the Chemical Industry Institute of Technology, now the Hamner Institutes for Health Sciences.

    Carlson holds a master's degree in toxicology from the University of Arizona, a bachelor's degree in biology from Roanoke College in Virginia and a 2012 certificate of achievement in alliance management from the Association of Strategic Alliance Professionals.

    Back to Top ▲

  • Kliewer named director of human resources for IU School of Medicine

    Ray Kliewer has been named director of human resources at the IU School of Medicine.

    Kliewer joined the IU School of Medicine on Jan. 26 from Heartland Food Product Group in Carmel, Ind., where he served as senior business director. He has over 20 years' experience in human resource at a variety of industries and companies, and has initiated talent development programs, culture change initiatives and process improvement programs at these organizations.

    In this position, Kliewer will be responsible the school's talent management infrastructure as well as creating and implementing strategies to attract, develop and retain a purpose-driven, performance-oriented and principles-led workforce. He will oversee the assessment and development of employees through the execution of initiatives and programs; identify recommend opportunities to improve and align supporting systems; and direct "best practices" to help the school achieve a higher level of effectiveness for its constituents.

    Kliewer holds a master's of education degree in human resource development and bachelor's degree in finance from the University of Louisville. He also has been an adjunct professor at the Kelley School of Business in Indianapolis since 2009.

    Kliewer succeeds Deb Cowley, who will focus exclusively on her role as director of the IU School of Medicine Office of Academic Administration.  

    Back to Top ▲

  • Porter to lead programs and evaluation for Office of Diversity Affairs

    Paul Porter, Ph.D., has been named program and evaluation director for the Office of Diversity Affairs at the IU School of Medicine.

    Dr. Porter joins IU from University of Scranton, where he most recently served as director of multicultural affairs. Prior to the University of Scranton, he served as a communication instructor, speech and debate coach, and first year experience professional at institutions including IUPUI and Marian University.

    Dr. Porter's work engages the intersection of higher education and cultural studies with an emphasis on multicultural competence in student affairs administration, racial identity and campus experiences for men of color. He is currently working on creating a framework to assess multicultural campus climates. Recently, he appeared on the online show "Student Affairs Live" as part of a panel discussing ways to confront racism on campus.  

    A native of Indianapolis, Dr. Porter holds a doctorate in higher education administration from Indiana State University as well as bachelor’s and master’s degrees in communication studies from Ball State University and Eastern Michigan University.

    Back to Top ▲

Student Showcase

  • Two students named 2015 Slemenda Scholars

    Two IUSM first-year students will gain hands-on experience this summer at Moi University in Eldoret, Kenya, as the 2015 Slemenda Scholars. 

    Jade Davis of Muncie, Ind., a first-year student at IU School of Medicine-South Bend, and Lakshmi Nemani of West Lafayette, Ind., a first-year medical student at the IU School of Medicine-Lafayette, will spend two months learning about health care through work with AMPATH, or the Academic Model Providing Access to Healthcare.

    Slemenda Scholars attend classes, make rounds in the hospital, work with ongoing field projects conducted by AMPATH faculty, and live with Kenyan medical students during their time in Eldoret, as well as serve as IU School of Medicine ambassadors to the partnership, including blogging on the AMPATH website. The scholarship provides support for travel, room and board.

    AMPATH is a partnership between Moi University, Moi Teaching and Referral Hospital and a consortium of 11 North American academic health centers led by IU. Over the past two decades, AMPATH has grown into one of the most comprehensive programs in sub-Saharan Africa to combat HIV/AIDS. The program continues to build on this success through providing primary care, chronic disease management and many other programs that support the overall health of the Kenyan people. 

    The award is named after the late IU School of Medicine epidemiologist Charles Slemenda, DrPH.

    Back to Top ▲


  • Seventh annual Teaching Skills in International Research Ethics worship

    The seventh annual Teaching Skills in International Research Ethics worship will be April 15 to 17 in the Health Information and Translational Sciences Building.

    TaSkR is hosted by the IU-Moi University Academic Research Ethics Partnership, a program supported by a five-year grant from the Fogarty International Center at the National Institutes of Health, and is designed to build research ethics capacity at both universities. This year's theme is "Epidemic Ethics."

    The event will help prepare participants to learn pedagogical methods and acquire skills for teaching international research ethics. Faculty and students involved in, or interested in, teaching and mentoring students in international research settings and experts in international research ethics, including those from other Fogarty-funded programs, are encouraged to attend.

    This is a free workshop but registration is required. The registration deadline is Wednesday, April 8.

    This event is sponsored by the IU Center fo Bioethics, Moi University and the Moi Teaching and Referral Hospital in Eldoret, Kenya. Support for the development of this workshop is provided by grant R25TW006070 from the Fogarty International Center at the National Institutes of Health.

    Questions to

    Back to Top ▲

  • Indiana Diabetes Research Center Pilot and Feasibility Program applications sought

    A primary research-related activity of the Indiana Diabetes Research Center's Pilot and Feasibility program is to foster the development of new diabetes-related investigators and provide seed-support for innovative, high-risk projects. The Indiana Diabetes Research Center's Pilot and Feasibility program would like to fund three meritorious proposals requesting up to $25,000.

    This funding opportunity announcement invites applications from investigators at the IU School of Medicine on the IUPUI campus. The program will be particularly directed at new investigators and established investigators new to diabetes-related research. The program will also consider established diabetes investigators pursuing high impact/high risk projects or projects that are a significant departure from their usual work. The IUSM-IUPUI campuses are ideal for establishing interdisciplinary collaborations and forging new partnerships between basic scientists and clinical researchers, and such collaborations are encouraged. Work supported by these funds is expected to lead to submissions of major extramural grants (R01/equivalent NIH, major foundation awards, Department of Defense, etc.). New investigators must have no prior R01 funding, and all proposals must be directed towards basic biomedical, clinical, or translational research questions on cellular and molecular metabolism related to diabetes/obesity/metabolic syndrome, clinical and outcomes research in diabetes and obesity, complications of diabetes and obesity, islet function and survival, and/or nutrition and physiology of obesity.

    Applicants should submit a letter of intent by 5 p.m. Wednesday, April 1. The deadline for applications is 5 p.m. Friday, May 1. The letters of intent and applications must be received via email at

    For more information see the application guidelines or email   

    Back to Top ▲

  • Core Equipment Grant applications due March 20

    The Indiana Clinical and Translational Sciences Institute is seeking proposals from Indiana CTSI-designated cores at the IU School of Medicine requesting support for the purchase of equipment, software or other resources that enhance the research environment and contribute to the research mission of the School and the Indiana CTSI.

    Proposals from $5,000 to $100,000 will be accepted for this proposal. Proposals for equipment costing more than $100,000 will be considered if matching funds are identified. 

    Complete proposals are due 5 p.m. Friday, March 20.

    For additional application instructions or to apply, visit the Indiana CTSI grants portal and log in using your institutional username and password. Applications instructions are located under "Indiana CTSI/IUSM Core Equipment Funding - 2015.03."

    Questions to

    Back to Top ▲

  • Oral and maxillofacial surgery chair sought

    The IU School of Dentistry seeks a visionary academic leader to serve as the chair of the oral and maxillofacial surgery.

    Applicants should have a strong background in academic leadership, research, and teaching. Administrative expectations include leadership of the departmental faculty, staff, and students, programmatic oversight in both pre-doctoral and post-doctoral education, strategic recruitment of outstanding faculty, fiscal responsibilities and planning.   

    In addition to academic leadership experience, candidates should possess a national reputation in the discipline of oral maxillofacial surgery, documented success in leading strategic initiatives and demonstrate a record of scholarship and research in oral maxillofacial surgery.

    This position will work closely with faculty at the IU School of Medicine.

    To apply, email with the subject line #IN-DENT 14010. Please include one PDF containing a short letter of interest noting key leadership experiences and/or approaches, and a curriculum vitae. Application deadline is March 16.

    For more information, see the complete position description

    Back to Top ▲